BeOne Medicines Ltd.
ONCAPI behind this page
ONC FY 2025 request
Playground key active
/api/financials?ticker=ONC&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 5,343,033 | 3,810,241 | +40.2% |
Show Product Lines breakouts |
|||
| Amgen royalty revenue · Novartis | 40,733 | 7,841 | +419.5% |
| Novartis broad markets revenue · Novartis | 17,598 | 18,259 | -3.6% |
| Other revenue | 60,972 | 30,695 | +98.6% |
| Other revenue · Novartis | 60,972 | 30,695 | +98.6% |
| Other revenue · Ociperlimab | 17,598 | 18,259 | -3.6% |
| Other · CN | 20,168 | 20,608 | -2.1% |
| Other · Europe | 1,726 | 3,119 | -44.7% |
| Other · Novartis | 2,641 | 4,595 | -42.5% |
| Other · Ociperlimab | 17,598 | 18,259 | -3.6% |
| Other · US | 39,078 | 6,968 | +460.8% |
| Product | 5,282,061 | 3,779,546 | +39.8% |
| Product · BLINCYTO® | 104,224 | 74,331 | +40.2% |
| Product · BRUKINSA® | 3,928,489 | 2,644,226 | +48.6% |
| Product · CN | 1,659,363 | 1,390,699 | +19.3% |
| Product · Europe | 609,643 | 359,507 | +69.6% |
| Product · KYPROLIS® | 74,974 | 66,171 | +13.3% |
| Product · Other | 83,691 | 96,070 | -12.9% |
| Product · Other | 171,809 | 78,810 | +118.0% |
| Product · POBEVCY® | 47,400 | 53,509 | -11.4% |
| Product · TEVIMBRA® | 737,304 | 620,836 | +18.8% |
| Product · US | 2,841,246 | 1,950,530 | +45.7% |
| Product · XGEVA® | 305,979 | 224,403 | +36.4% |
Show Geography breakouts |
|||
| CN | 1,679,531 | 1,411,307 | +19.0% |
| Europe | 611,369 | 362,626 | +68.6% |
| Other | 171,809 | 78,810 | +118.0% |
| US | 2,880,324 | 1,957,498 | +47.1% |
| Cost of Revenue (FY) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 668,540 | 594,089 | +12.5% |
| Gross Profit | 4,674,493 | 3,216,152 | +45.3% |
| Research & Development | 2,145,868 | 1,953,295 | +9.9% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 29,372 | 427,129 | -93.1% |
Show Counterparty Name breakouts |
|||
| Amgen, Inc | 104,143 | 75,165 | +38.6% |
| Selling, General & Administrative | 2,081,489 | 1,831,056 | +13.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 69,530 | 357,103 | -80.5% |
| Total Costs & Expenses | 4,227,357 | 3,784,351 | +11.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -2,193 | 711,006 | -100.3% |
| Operating Income | 447,136 | -568,199 | +178.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 2,193 | -711,006 | +100.3% |
| Interest Income | 70,505 | 69,641 | +1.2% |
| Interest Expense | -58,234 | -21,805 | -167.1% |
| Other Non-Operating Income (Expense) | -42,553 | -12,638 | -236.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 305,686 | 63,522 | +381.2% |
| Income Before Taxes | 416,854 | -533,001 | +178.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 286,992 | -644,383 | +144.5% |
| Income Tax Expense (Benefit) | 129,921 | 111,785 | +16.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 59 | 403 | -85.4% |
| Net Income | 286,933 | -644,786 | +144.5% |
Show Equity Components breakouts |
|||
| Retained Earnings | 286,933 | -644,786 | +144.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 286,933 | -644,786 | +144.5% |
| EPS (Basic) | 0.2 | -0.47 | +142.6% |
| EPS (Diluted) | 0.19 | -0.47 | +140.4% |
| Wtd Avg Shares (Basic) | 1,417,803,727 | 1,368,746,793 | +3.6% |
| Wtd Avg Shares (Diluted) | 1,474,829,908 | 1,368,746,793 | +7.8% |
| Earnings Per American Depository Share Basic | 2.63 | -6.12 | +143.0% |
| Earnings Per American Depository Share Diluted | 2.53 | -6.12 | +141.3% |
| Weighted Average Number Of American Depository Shares Outstanding Basic | 109,061,825 | 105,288,215 | +3.6% |
| Weighted Average Number Of American Depository Shares Outstanding Diluted | 113,448,454 | 105,288,215 | +7.8% |
| Comprehensive Income | 357,737 | -694,328 | +151.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 357,737 | -694,328 | +151.5% |
| Other Comprehensive Income | 70,804 | -49,542 | +242.9% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 70,804 | -49,542 | +242.9% |
| Income Loss From Equity Method Investments (FY) | — | — | — |
Show Income Statement Location breakouts |
|||
| Other Operating Income Expense | -14,982 | -10,275 | -45.8% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 4,547,530 | 2,627,410 | +73.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 584,216 | 400,135 | +46.0% |
| Accounts Receivable | 865,080 | 676,278 | +27.9% |
| Inventory | 608,227 | 494,986 | +22.9% |
| Prepaid Expenses & Other Current Assets | 212,752 | 192,919 | +10.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 180,495 | 249,016 | -27.5% |
| Total Current Assets | 6,233,589 | 3,991,593 | +56.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 764,711 | 649,151 | +17.8% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 1,641,678 | 1,578,423 | +4.0% |
| Operating Lease Right-of-Use Assets | 148,184 | 139,309 | +6.4% |
Show Property Plant And Equipment By Type breakouts |
|||
| Building | 69,306 | 60,639 | +14.3% |
| Land | 78,878 | 78,670 | +0.3% |
| Intangible Assets | 62,704 | 51,095 | +22.7% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Developed Technology Rights | 62,195 | 50,519 | +23.1% |
| Other Intangible Assets | 509 | 576 | -11.6% |
Show Income Statement Location breakouts |
|||
| Cost Of Sales | 62,195 | — | — |
| Selling General And Administrative Expenses | 509 | — | — |
| Other Non-Current Assets | 102,418 | 160,490 | -36.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 41,658 | 114,728 | -63.7% |
| Assets Noncurrent | 1,954,984 | 1,929,317 | +1.3% |
| Total Assets | 8,188,573 | 5,920,910 | +38.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 5,831,268 | 4,576,480 | +27.4% |
| Long Term Investments | 61,678 | 128,933 | -52.2% |
| Current Liabilities | |||
| Accounts Payable | 479,035 | 404,997 | +18.3% |
Show Counterparty Name breakouts |
|||
| Amgen, Inc · Related Party | 79,097 | 116,563 | -32.1% |
| Accrued Liabilities | 1,109,120 | 803,713 | +38.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 254,815 | 312,957 | -18.6% |
| Taxes Payable Current | 41,625 | 25,930 | +60.5% |
| Operating Lease Liability Current | 20,698 | 17,576 | +17.8% |
| Research And Development Cost Share Liability Current Portion | 64,345 | 111,154 | -42.1% |
| Long Term Debt Royalty Liability Current | 56,714 | — | — |
| Current Portion of Long-Term Debt | 57,293 | 851,529 | -93.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 9,063 | 762,146 | -98.8% |
| Total Current Liabilities | 1,828,830 | 2,214,899 | -17.4% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 581,417 | 1,186,257 | -51.0% |
| Non-Current Liabilities | |||
| Long-Term Debt | 961,913 | 166,484 | +477.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 836,369 | — | — |
| Long Term Debt Royalty Liability Noncurrent | 850,242 | — | — |
| Operating Lease Liabilities | 52,940 | 44,277 | +19.6% |
| Deferred Tax Liabilities | 53,209 | 42,007 | +26.7% |
| Other Non-Current Liabilities | 80,245 | 66,735 | +20.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 52,288 | 3,714 | +1307.9% |
| Liabilities Noncurrent | 1,998,549 | 373,789 | +434.7% |
| Total Liabilities | 3,827,379 | 2,588,688 | +47.9% |
Show Debt Instrument breakouts |
|||
| Royalty Payments | 906,956 | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 1,470,074 | 1,244,257 | +18.1% |
| Long-Term Debt | 836,369 | — | — |
Show Debt Instrument breakouts |
|||
| Long Term Bank Loan Dated April 4 2018 · China Construction Bank | 21,450 | 41,100 | -47.8% |
| Long Term Bank Loan Dated January 22, 2020 · China Merchants Bank | 20,224 | 27,987 | -27.7% |
| Long Term Bank Loan Dated July 29, 2022 · China CITIC Bank | 57,900 | 64,377 | -10.1% |
| Long-term bank November 9, 2020 · China Merchants Bank | 25,970 | 33,020 | -21.4% |
Show Long-Term Debt Type breakouts |
|||
| Loans Payable | 125,544 | 166,484 | -24.6% |
| Stockholders' Equity | |||
| Common Stock | 144 | 138 | +4.3% |
| Additional Paid-In Capital | 12,759,137 | 12,087,908 | +5.6% |
| Accumulated Other Comprehensive Income | -78,184 | -148,988 | +47.5% |
| Retained Earnings | -8,319,903 | -8,606,836 | +3.3% |
| Total Stockholders' Equity | 4,361,194 | 3,332,222 | +30.9% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -78,184 | -148,988 | +47.5% |
| Accumulated Translation Adjustment | -66,252 | -135,552 | +51.1% |
| Additional Paid In Capital | 12,759,137 | 12,087,908 | +5.6% |
| Common Stock | 144 | 138 | +4.3% |
| Other Adjustments | -11,932 | -13,436 | +11.2% |
| Retained Earnings | -8,319,903 | -8,606,836 | +3.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 4,361,194 | 3,332,223 | +30.9% |
| Total Liabilities & Equity | 8,188,573 | 5,920,910 | +38.3% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 5,831,268 | 4,576,480 | +27.4% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 141,686 | 171,762 | -17.5% |
| Stock-Based Compensation | 510,857 | 441,618 | +15.7% |
| Acquired In Process Research And Development | 691 | 60,000 | -98.8% |
| Amortization Of Research And Development Financing Liability | -101,095 | -73,226 | -38.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -101,095 | -73,226 | -38.1% |
| Equity Method Investments And Securities Other Than Temporary Impairment | 75,626 | 6,838 | +1006.0% |
| Gain Loss On Investments | -596 | -17,184 | +96.5% |
| Increase Decrease In Noncash Interest Expense | 14,872 | — | — |
| Deferred Income Taxes And Tax Credits | 9,469 | 25,983 | -63.6% |
| Other Operating Activities Cash Flow Statement | -2,953 | 11,163 | -126.5% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 81,247 | 31,651 | +156.7% |
| Change in Accounts Receivable | -164,954 | -329,443 | +49.9% |
| Change in Inventory | -93,168 | -91,496 | -1.8% |
| Increase Decrease In Other Operating Assets | 37,164 | 45,126 | -17.6% |
| Change in Accounts Payable | 79,833 | 121,497 | -34.3% |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | 311,762 | 111,354 | +180.0% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 56,259 | 627,307 | -91.0% |
| Change in Deferred Revenue | 1,293 | 633 | +104.3% |
| Increase Decrease In Other Operating Liabilities | 18,968 | -14,838 | +227.8% |
| Net Cash from Operations | 1,127,580 | -140,631 | +901.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -133,578 | -143,472 | +6.9% |
| Deferred Income Taxes | 9,469 | 26,007 | -63.6% |
Show Income Tax Authority breakouts |
|||
| CN | 5,450 | 180 | +2927.8% |
| Other | -2,020 | 2,271 | -188.9% |
| US | 6,039 | 23,556 | -74.4% |
| Change in Prepaid & Other Assets (FY) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | 27,544 | 1,053 | +2515.8% |
| Investing Activities | |||
| Capital Expenditures | -185,839 | -492,663 | +62.3% |
| Payments To Purchase In Process Research And Development | -60,691 | -31,800 | -90.9% |
| Payments To Acquire Intangible Assets | -20,000 | -4,674 | -327.9% |
| Payments To Acquire Longterm Investments | -11,834 | -19,006 | +37.7% |
| Proceeds From Sale Of Available For Sale Securities Debt | 3,446 | 2,655 | +29.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -954 | -2,628 | +63.7% |
| Other Investing Activities | -1,237 | -2,862 | +56.8% |
Show Consolidated Entities breakouts |
|||
| Parent Company | -9,670 | -17,735 | +45.5% |
| Net Cash from Investing | -276,155 | -548,350 | +49.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 96,886 | -441,116 | +122.0% |
| Financing Activities | |||
| Proceeds From Other Debt | 911,000 | — | — |
| Proceeds From Long Term Lines Of Credit | 850,586 | 9,053 | +9295.6% |
Show Debt Instrument breakouts |
|||
| Long Term Bank Loan Dated July 29, 2022 · China CITIC Bank | 1,442 | — | — |
| Repayments Of Long Term Debt | -35,680 | -28,031 | -27.3% |
Show Debt Instrument breakouts |
|||
| Long-term bank April 4, 2018 · China Construction Bank | -17,225 | — | — |
| Short Term Bank Loan Dated November 9, 2020 · China Merchants Bank | -8,287 | — | — |
| Proceeds From Short Term Debt | 233,676 | 868,270 | -73.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 139,453 | 813,058 | -82.8% |
| Repayments Of Short Term Debt | -1,044,781 | -704,216 | -48.4% |
Show Debt Instrument breakouts |
|||
| Short Term Bank Loan Dated January 22, 2020 · China Construction Bank | -8,726 | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | -893,987 | -593,898 | -50.5% |
| Debt Issuance Costs | -23,392 | — | — |
| Tax Withholding for Share Compensation | -24,195 | — | — |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 196,281 | 45,373 | +332.6% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 196,281 | 45,371 | +332.6% |
| Repayment Of Sale Of Future Royalty Liability | -4,044 | — | — |
| Proceeds From Payments For Other Financing Activities (FY) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Parent Company | -47,587 | — | — |
| Net Cash from Financing | 1,059,451 | 193,449 | +447.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 244,746 | 264,531 | -7.5% |
| Supplemental | |||
| Restricted Cash And Cash Equivalents At Carrying Value | 41,284 | 9,312 | +343.3% |
| Restricted Cash And Cash Equivalents Noncurrent | 20,833 | 2,025 | +928.8% |
| Interest Paid Including Capitalized Interest | 52,452 | 51,175 | +2.5% |
| Unpaid Capital Expenditures | 57,283 | 70,314 | -18.5% |
| Income Taxes Paid | 100,681 | 69,430 | +45.0% |
| Interest Paid | 34,428 | 19,723 | +74.6% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 60,024 | -51,705 | +216.1% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 6,228 | -4,356 | +243.0% |
| Net Change in Cash | 1,970,900 | -547,237 | +460.2% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 214,282 | -324,413 | +166.1% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4,609,647 | 2,638,747 | +74.7% |
Show Consolidated Entities breakouts |
|||
| Parent Company | 614,417 | 400,135 | +53.6% |
Values in thousands USD. Source: SEC EDGAR 10-K filing.